← Leaderboards
Ho-Lun Wong
Temple Univ Of The Commonwealth
$3,857,053
Attributed
$3,857,053
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $475.5K · FY2012–25$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,857,053 · 4
By mechanism
R01$3,540,053 · 2
R03$317,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Santiago Orrego$1,278,140
- Vincent Tam$2,030,604
Others in their field
Top investigators on “Nanocarrier”
- Gang Bao · Georgia Institute Of Technology$14,615,641
- Vladimir R Muzykantov · University Of Pennsylvania$13,445,420
- Kit S Lam · University Of California At Davis$12,221,058
- Reza Abdi · Brigham And Women'S Hospital$10,862,613
- Madhavan P Nair · State University Of New York At Buffalo$10,384,112
- Vladimir P Torchilin · Northeastern University$10,311,529
Research focus
NanocarrierLearningPropertyDevicesPenetrationToxic EffectIn VivoGenerationsNanotechnologyBasePharmaceutical PreparationsIn VitroHybridsMalignant NeoplasmsMillimeterNormal Tissue MorphologyEngineeringDrug KineticsPublic HealthDoseBiodistributionNanomedicinePharmacotherapySite
Grant awards (13)
An exploratory study of a new pH-responsive, ionizable hybrid nanocarrier for enchancing drug accumulation in bacterial biofilms$158,500
R03 · FY2025 · AI · contact PI
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones$396,250
R01 · FY2022 · AI · contact PI
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones$396,250
R01 · FY2021 · AI · contact PI
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones$396,250
R01 · FY2020 · AI · contact PI
New nanotechnology to enhance brain-delivery of antiretroviral drugs for treatment of HIV-associated neurocognitive disorder$79,250
R03 · FY2020 · NS · contact PI
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones$396,250
R01 · FY2019 · AI · contact PI
New nanotechnology to enhance brain-delivery of antiretroviral drugs for treatment of HIV-associated neurocognitive disorder$79,250
R03 · FY2019 · NS · contact PI
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones$396,250
R01 · FY2018 · AI · contact PI
Hybrid nanotechnology to target metastatic advanced prostate cancer$317,475
R01 · FY2016 · CA · contact PI
Hybrid nanotechnology to target metastatic advanced prostate cancer$317,475
R01 · FY2015 · CA · contact PI
Hybrid nanotechnology to target metastatic advanced prostate cancer$307,951
R01 · FY2014 · CA · contact PI
Hybrid nanotechnology to target metastatic advanced prostate cancer$298,427
R01 · FY2013 · CA · contact PI
Hybrid nanotechnology to target metastatic advanced prostate cancer$317,475
R01 · FY2012 · CA · contact PI